Clinical Trial Update: Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on a combination of ETV, TQ-A3334, and TQ-B2450 for chronic hepatitis B is in progress, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ETV (entecavir)
• TQ-A3334 (TQ-A3334)
• TQ-B2450

Snippet

Sponsor: Tongji Hospital | Conditions: Chronic Hepatitis b | Phase 2 | Status: UNKNOWN